At least one prominent hedge fund mogul who played the now-busted $55 billion AbbVie-Shire deal got out in the nick of time, The Post has learned.
Eric Mindich, one of a handful of hedgies who cut their trading teeth on Goldman Sachs' risk arb desk, told investors that his Eton Park Capital hedge fund firm decided to take its profits in Shire in September because of the risks associated with the deal.
Shire is based in Ireland, and AbbVie backed out of the deal after Washington moved to stop the so-called tax inversions.
hoped to take advantage of the country's lower tax rate in a tax-inversion deal.
But the Obama administration has been railing against the loss of revenue, and Treasury Secretary Jack Lew, on Sept 8, promised to crack down on inversions "in the very near future."
Shire shares tumbled 30 percent after AbbVie walked away from the deal on Wednesday.
decided to walk away from the deal on Wednesday, and Shire stock tumbled 30 percent.
Shire was Eton Park's fourth-best performing holding in September, Mindich said told investors in his third-quarter letter.
Another Goldman risk-arb veteran, Frank Brosens of Taconic Capital, didn't fare so well. Taconic was buying Shire as recently as this week and told investors in a call Thursday that the firm sold down its position when AbbVie nixed the deal.
Mindich and Brosens did not return calls for comment.
Anda sedang membaca artikel tentang
Hedge fund mogul Eric Mindich escapes AbbVie deal
Dengan url
http://bahayaprostat.blogspot.com/2014/10/hedge-fund-mogul-eric-mindich-escapes.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Hedge fund mogul Eric Mindich escapes AbbVie deal
namun jangan lupa untuk meletakkan link
Hedge fund mogul Eric Mindich escapes AbbVie deal
sebagai sumbernya
0 komentar:
Posting Komentar